This is the Board
of Directors of China Renji.
*Updated on 17 Jun 2010
Li Juewen, Chairman
Mr Li Juewen, aged 67, was
appointed as Chairman and Executive Director of the Company in
July 2009 and is a substantial shareholder of the Company. He
is also currently a Director of China Renji Medical (BVI) Limited,
a subsidiary of the Company. Mr Li, holding the title of Senior
Economist in the People’s Republic of China, possesses over 30
years of substantial experience in corporate development and management.
He was a Member of the 9th National Committee of the Chinese People’s
Political Consultative Conference (“CPPCC”) and a Member of the
Standing Committee of the CPPCC of Hunan Province. He was the
Chairman and President of Hunan Trading Company Limited established
in Hong Kong in 1985. From 1989 to 2000, Mr Li was a Director
of Hong Kong Hunan Sunshine Holdings Limited and was appointed
Chairman and President who was responsible for formulating forward-looking
corporate development strategies and the overall operations and
management of the company, allowing Hunan Sunshine Holdings Limited
rapidly developed into a multinational conglomerate engaging in
import and export trading, industrial investment, property development
and hotel management. Mr Li was also the Chairman of Shenzhen
Sunshine Hotel, a provincial minister graded Inspector of the
Department of Commerce of Hunan Province and the Chairman of Hunan
Kangda Voluntary Drug Rehabilitation Centre.
Guo Bao Ping, Chief Executive
Officer
Mr Guo Bao Ping, aged 53, was appointed as Executive
Director of the Company in March 2009. Subsequently, in May 2010,
he was also appointed as Chief Executive Officer of the Company
and holds a number of directorships in companies within the Group.
Mr Guo first joined the Company as a Vice President in December
2008, and was responsible for overseeing financial management,
corporate governance and overall management of the Company as
well as assisting the Chief Executive Officer in handling investments
and finance affairs with the aim to enhance the relationship between
the Company and the investors. Prior to this, he was a General
Manager of China Conic Import & Export Corporation, a General
Manager of China Trust & Investment Corp. for Foreign Economic
Relations and Trade and an Executive Director of Fotic Capital
Limited. Mr Guo possesses extensive experience in corporate finance
and operational management in Hong Kong and China with prominent
human relationship.
Wang Hai, Executive Director
Mr Wang Hai, aged 56, was re-designated as Executive
Director of the Company in May 2010. He was first appointed as
Non-executive Director of the Company in November 2009 and is
currently a Director of Anping Medical Treatment Technology (Wuhu)
Co., Ltd., a subsidiary of the Company, and a Legal Counsel of
the Company since December 2008. Mr Wang is a registered Lawyer
in China and an Arbitrator of the International Court of Arbitration
of the International Chamber of Commerce. He has been a Partner
at Beijing Forever Law Firm since 1999. Mr Wang holds a Bachelor's
Degree in Law from the Southwest University of Political Science
& Law and a Master's Degree in Law from Foreign Affairs College,
China.
Wang Yongchang, Non-executive Director
Professor Wang Yongchang, aged 63, was appointed
as Non-executive Director of the Company in May 2008. He is also
currently a Director of Anping Medical Treatment Technology (Wuhu)
Co., Ltd. and Wuhu Anping Medical Management Co., Ltd., both are
subsidiaries of the Company. Professor Wang graduated from the
PLA Seventh Medical University Hospital (since renamed the PLA
Third Military Medical University) — Faculty of Medicine in 1969.
He possesses over 30 years of surgical and clinical experience,
having acted as the Hospital Chief Executive of class 3 “PetroChina
Lanzhou Petrochemical Main Hospital” for 8 years. In 2003, he
was awarded the “National Trade Union of Hospitals Excellence
Award for Hospital Chiefs”. Professor Wang was also a Member of
the second and third congress of the Trade Union Management Division
of the Zhonghua Hospital Management Society. He is currently an
Officer of the Radiation Oncology Centre of the Main Hospital
of the Second Artillery Force of the People’s Liberation Army,
Beijing, the PRC.
Wu Zhenfang, Non-executive Director
Mr Wu Zhenfang, aged 63, was appointed as Non-executive
Director of the Company in November 2009. He is also currently
the Chairman of Wuhu Longyuan Investment Company Limited, a substantial
shareholder of the Company, and a Director and Vice President
of Anping Medical Treatment Technology (Wuhu) Co., Ltd., a subsidiary
of the Company. He has over 35 years of experience in hospital
management and clinical services. Mr Wu was a Member of the Shanghai
Municipal Health Bureau Hospital Level Vetting Committee and the
Shanghai Municipal Medical Ethics Society and a Standing Member
of the Shanghai Municipal Labour Hospital Management Association.
Mr Wu was the Vice President and Deputy Director of surgery of
the People’s Hospital of Shanghai Putuo District. He was also
the Independent Director of Shanghai Xinmei Real Estate Co., Ltd.
(listed on the Shanghai Stock Exchange) up to October 2009. Mr
Wu holds a Bachelor’s Degree from the Faculty of Medicine of the
Shanghai Second Medical University, China.
Pang Wai
Hong, Independent Non-executive Director
Mr Pang Wai Hong, aged 45, was appointed
as Independent Non-executive Director of the Company in August
2008. Mr Pang graduated from the National University of Ireland
with a Master of Science Degree in Finance in 1999 and holds a
Master of Lighting from Queensland University of Technology, Australia.
Mr Pang has been a Fellow Member of the Association of Chartered
Certified Accountants in London, the United Kingdom, since 1997
and has also been an Associate Member of the Hong Kong Institute
of Certified Public Accountants. Between June 2000 and March 2008,
Mr Pang served as the Chief Financial Officer and Company Secretary
of Singapore-listed People’s Food Holdings Limited, where he was
responsible for the finance and accounting functions, statutory
compliance and corporate governance affairs. Prior to that, Mr
Pang was an Audit Manager with the international accounting practice
of Deloitte Touche Tohmatsu from September 1992 to May 2000, where
he was responsible for carrying out due diligence, audits, accounting,
taxation, corporate finance and other compliance related matters.
Li Wing Chiu,
Independent Non-executive Director
Dr Li Wing Chiu, aged 45, was appointed
as Independent Non-executive Director of the Company in October
2008. He is presently a Managing Director of Neuf Capital Limited
and the Vice Chairman of 創冠金融國際有 限公司, both are private equity
investment holding companies engaged in equity investment. Dr
Li has substantial experience in corporate development and financial
investments. He was the Chairman of Xiamen Foreign Business Exchange
Association and the Head of Shenzhen City Economic Exchange Center.
Dr Li holds a Doctor’s Degree in Economics from Xiamen University,
China.
>> Board Committees
